Insider share sale at current price of US$61.62 raises caution. More insider shares sold than bought over the past year is concerning. High insider ownership could indicate alignment of management and shareholder interests.
More insider selling than buying at Terex in the last three months and over the past year could be seen as a bearish signal. Despite Terex's profitability and growth, the low level of insider ownership might suggest a lack of alignment between insiders and shareholders.
Market sentiment seems negative towards the company, indicated by its low P/E ratio of 7.78. Despite recent insider buying, earnings and revenue growth trends are deemed crucial for future stock performance.
Despite modest growth projections, Terex's current undervaluation suggests it may be a good time to increase holdings in this stock. The future outlook is not fully reflected in the current share price, indicating it's not too late to invest.
The upwards trend in Terex's ROCE indicates improvements in the company's efficiencies which is taken as a positive sign. It's worth researching the company further to see if these trends are likely to persist.
特雷克斯股票讨论区
近5年毛利率基本在19%左右,只有2020年跌到了17.5%。净资产收益率则从9.5%上升到21.75%,只有2020年为-1.1%,5年平均为9.4%,看起来没什么吸引力。
营收2020年触底,2021年仍没恢复到2019年的水平。营业利润也类似,2021年接近了2019年水平。由于2019年有1.55亿的停止经营亏损,所以显得2021年净利润大幅超过2019年,如果刨除这部分影响,2019年净利润增长并不多。
2022前两季度营收、营业利润和净利润分别增长9.3%,-3%,10.5%,净利润增长主要来自利息费用和其他费用下降。
目前11.83倍市盈率,11.15倍市盈率TTM吸引力不大。
专栏Today's pre-market stock movers: TWTR, UPS, HSBC, JBLU and more
• $Avadel Pharmaceuticals(AVDL.US)$ +36.1% (continued volatility)
• $Gamida Cell(GMDA.US)$ +20.57% (announces FDA clearance of investigational IND and removal of clinical hold for GDA-201)
• $Venator Materials(VNTR.US)$ +14.61% (VNTR receives $85 mln settlement from Tronox)
• $欧伊诺(OI.US)$ +10.9% (earnings report)
• $康宁(GLW.US)$ +9% (earnings report)
• $Arch Resources(ARCH.US)$ +7.2% (earnings report)
• $宣伟公司(SHW.US)$ +6.1% (ea...
专栏Top upgrades and downgrades on 4/8
• $Afya Ltd(AFYA.US)$: Credit Suisse Upgrades to Outperform from Neutral - PT $19 (from $18)
• $Appfolio(APPF.US)$: KeyBanc Upgrades to Overweight from Sector Weight - PT $143
• $罗宾逊物流(CHRW.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $117 (from $91)
• $Coupang(CPNG.US)$: Goldman Sachs Upgrades to Conviction Buy from Buy - PT $37
• $Gatos Silver(GATO.US)$: RBC Capital Upgrades to Sector Perform from Underperform - PT $4
• $ITT Inc(ITT.US)$: UBS Upgr...
暂无评论